VEGFA and Familial prostate cancer: In breast and prostate cancers, for example, MSCs increased the levels of pro-angiogenic factors such as vascular endothelial growth factor (VEGF), macrophage inflammatory protein-2 (MIP-2), TGF-β, and IL-6.